(Q33498360)

27 July 2017

title

Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation (English)

1 reference

27 July 2017

Chu-Young Kim

5

0 references

Ludvig M Sollid

6

object named as

Ludvig M Sollid

1 reference

27 July 2017

Lars-Egil Fallang

1

1 reference

27 July 2017

Elin Bergseng

2

1 reference

27 July 2017

Kinya Hotta

3

1 reference

27 July 2017

Axel Berg-Larsen

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

30 August 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

10

1 reference

27 July 2017

page(s)

1096-1101

1 reference

Coeliac disease: dissecting a complex inflammatory disorder

27 July 2017

cites work

1 reference

Celiac disease: pathogenesis of a model immunogenetic disease

21 January 2018

1 reference

Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients

21 January 2018

1 reference

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

21 January 2018

1 reference

A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease

21 January 2018

1 reference

Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules

21 January 2018

1 reference

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

21 January 2018

1 reference

Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential

21 January 2018

1 reference

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses

21 January 2018

1 reference

Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation

21 January 2018

1 reference

Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule

21 January 2018

1 reference

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule

21 January 2018

1 reference

Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule

21 January 2018

1 reference

Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM

21 January 2018

1 reference

Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides

21 January 2018

1 reference

Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.

21 January 2018

1 reference

Irreversible association of peptides with class II MHC molecules in living cells.

21 January 2018

1 reference

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes

21 January 2018

1 reference

Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy

21 January 2018

1 reference

Probing the Specificity Determinants of Amino Acid Recognition by Arginase † ‡

21 January 2018

1 reference

T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation

21 January 2018

1 reference

HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease

21 January 2018

1 reference

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

21 January 2018

1 reference

Crystal structure of I-Ak in complex with a dominant epitope of lysozyme

21 January 2018

1 reference

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

21 January 2018

1 reference

Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule

21 January 2018

1 reference

Staining of celiac disease-relevant T cells by peptide-DQ2 multimers

21 January 2018

1 reference

Characterization of an HLA-DQ2-specific monoclonal antibody. Influence of amino acid substitutions in DQ beta 1*0202.

21 January 2018

1 reference

Mediation by HLA-DM of dissociation of peptides from HLA-DR

21 January 2018

1 reference

UCSF Chimera--a visualization system for exploratory research and analysis

21 January 2018

1 reference

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

21 January 2018

1 reference

Structural principles of MHC class II antigen presentation

21 January 2018

1 reference

12 December 2020

On the HLA-DQ(α1*0501, β1*0201)-associated susceptibility in celiac disease: A possible gene dosage effect ofDQB1*0201

1 reference

12 December 2020

Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order

1 reference

12 December 2020

Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule

1 reference

12 December 2020

The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance

1 reference

12 December 2020

Identifiers

DOI

10.1038/NI.1780

1 reference

27 July 2017

1 reference